Patents by Inventor Mélanie Vausort

Mélanie Vausort has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10704100
    Abstract: The application discloses circRNAs as new biomarkers for the development of heart failure after myocardial infarction; methods for the prediction and diagnosis of heart failure are provided based on measuring said one or more circRNAs; and kits and devices for measuring said circRNAs and/or performing said methods. Further provided are methods for treating patients at risk of heart failure based on the evaluation of said one or more circRNAs.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: July 7, 2020
    Assignee: Luxembourg Institute of Health (LIH)
    Inventors: Yvan Devaux, Mélanie Vausort, Lu Zhang
  • Publication number: 20180265923
    Abstract: The application discloses circRNAs as new biomarkers for the development of heart failure after myocardial infarction; methods for the prediction and diagnosis of heart failure are provided based on measuring said one or more circRNAs; and kits and devices for measuring said circRNAs and/or performing said methods. Further provided are methods for treating patients at risk of heart failure based on the evaluation of said one or more circRNAs.
    Type: Application
    Filed: September 15, 2016
    Publication date: September 20, 2018
    Applicant: Luxembourg Institute of Health (LIH)
    Inventors: Yvan Devaux, Mélanie Vausort, Lu Zhang
  • Publication number: 20160188835
    Abstract: Provided is a method of identifying myocardially-infarcted patients having an increased risk of developing a heart condition.
    Type: Application
    Filed: September 22, 2015
    Publication date: June 30, 2016
    Applicant: LUXEMBOURG INSTITUTE OF HEALTH
    Inventors: Yvan Devaux, Daniel R. Wagner, Francisco Azuaje, Mélanie Vausort
  • Publication number: 20160060697
    Abstract: The present invention provides compositions and kits comprising miRNAs useful for the monitoring or diagnosis of heart disease in an individual. In particular, the compositions of the invention can be used for the prognosis of patients towards the development of left ventricular remodeling having suffered from an acute myocardial infarction. In addition, the present invention provides pharmaceutical compositions for the treatment of left ventricular remodeling.
    Type: Application
    Filed: November 27, 2013
    Publication date: March 3, 2016
    Applicant: LUXEMBOURG INSTITUTE OF HEALTH
    Inventors: Yvan Devaux, Mélanie Vausort, Lu Zhang, Daniel Wagner, Iain Squire
  • Publication number: 20110294683
    Abstract: Provided is a method of identifying myocardially-infarcted patients having an increased risk of developing a heart condition.
    Type: Application
    Filed: October 30, 2009
    Publication date: December 1, 2011
    Applicant: Centre de Recherche Public de la Sant'e
    Inventors: Yvan Devaux, Daniel R. Wagner, Francisco Azuaje, Mélanie Vausort